According to a report by the Japanese news agency on December 12, Japanese actor Murasugi Seminosuke has admitted to allegations of receiving marijuana and other controlled substances on multiple occasions.
Tomokazu Murasugi, whose real name is Tomokazu Murasugi, is 58 years old and resides in Adachi Ward, Tokyo. He has been suspected of receiving marijuana and other drugs multiple times between November last year and January this year.
According to reports, it has been revealed that Villager Sugi came into contact with drug dealers through an online medium and communicated with them using encrypted social networking services. Subsequently, the drugs were received through a mail delivery service. During the investigation into the drug dealers' bank accounts, the police discovered transaction records associated with Sugi.
In the world of theater, Murasugi is a familiar face, having played significant roles in numerous plays and stage productions, including NHK's historical drama series.
After his arrest, Village Sugii's theater group "Otona Keikaku" released a statement on their official website. They stated that they are currently verifying the facts with their lawyer and sincerely apologize to anyone concerned about this matter. They assure that they will promptly address the issue.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
